Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Heli Xinjian Pharmaceutical is a prominent Chinese pharmaceutical company headquartered in Jiaxing, Zhejiang Province, specializing in the pediatric and gastroenterology sectors. The company integrates research and development, large-scale manufacturing, and a comprehensive domestic sales network to provide high-quality healthcare solutions. Its product portfolio is anchored by the Xinjian brand, which includes a variety of probiotics, digestive enzymes, and respiratory treatments specifically formulated for children. Heli Xinjian operates modern, GMP-certified production facilities and maintains strategic collaborations with academic institutions to drive innovation in pediatric medicine. The company is recognized as a key player in China's specialized pharmaceutical market, focusing on addressing unmet needs in children's health and digestive wellness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 浙江核力欣健药业.